Prescription Rates for Antiplatelet Therapy (APT) in Coronary Artery Disease (CAD) – What Benchmark are We Aiming at in Continuing Medical Education (CME)?

References

• Moore DE, Green JS, Gallis HA. Achieving desired results and improved outcomes: integrating planning and assessment throughout learning activities. JCEHP. 2009;29:1–6.
   Google Scholar
• Busch MA, Kuhnert R. 12-Month prevalence of coronary heart disease in Germany. J Health Monit. 2017;2(1):58–63. .
   Google Scholar
• Hagen B, Griebenow R, Altenhofen L, et al. Time course of change in prescription behaviour after targeted continuing medical education in a closed loop system of repeated standardized documentation and feedback. J Eur CME. 2014;3:24697.
   Google Scholar
• Bebb O, Hall M, Fox KAA, et al. Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the UK Myocardial Ischemia National Audit Project (MINAP) register. Eur Heart J. 2017;38:974–982.
   Google Scholar
• Bruggmann C, Iglesias JF, Gex-Fabry M, et al. Long-term quality of prescription for ST-Segment-Elevation Myocardial Infarction (STEMI) patients: a real world 1-year follow-up study. Am J Cardiovasc Drugs. 2020;20:105–115.
   Web of Science ®Google Scholar
• Czarny MJ, Nathan AS, Yeh RW, et al. Adherence to dual antiplatelet therapy after coronary stenting: a systematic review. Clin Cardiol. 2014;37(8):505–513.
   Web of Science ®Google Scholar
• Engel J, Damen NL, van der Wulp I, et al. Adherence to cardiac practice guidelines in the management of non-ST-elevation acute coronary syndromes: a systematic literature review. Curr Cardiol Rev. 2017;13:3–27.
   Web of Science ®Google Scholar
• Ardoino I, Rossio R, Di Blanca D, et al. Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people. Br J Clin Pharmacol. 2017;83:2528–2540.
   PubMed Web of Science ®Google Scholar
• Hall M, Bebb O, Dondo TB, et al. Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction. Eur Heart J. 2018;39:3798–3806.
   Google Scholar
• Wang R, Neuenschwander FC, Filho AL, et al. Use of evidence-based interventions in acute coronary syndrome- subanalysis of the ACCEPT registry. Arq Bras Cardiol. 2014;102(4):319–326.
   Web of Science ®Google Scholar
• Auer R, Gencer B, Räber L, et al. Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications. PLoS One. 2014;9(3):e93147.
   Web of Science ®Google Scholar
• Bhagwat MM, Woods JA, Dronovalli M, et al. Evidence-based intervention in primary care following acute coronary syndrome in Australia and New Zealand: a systematic scoping review. BMC Cardiovasc Disord. 2016;16:214–228.
   Web of Science ®Google Scholar
• Davis AM, Vinci LM, Okwuosa TM, et al. Cardiovascular health disparities: a systematic review of health care interventions. Med Care Res Rev. 2007;64(5 Suppl.):29S–100S.
   Web of Science ®Google Scholar
• Lee JH, Bae MH, Yang DH, et al. Contemporary trends of optimal evidence-based medical therapy at discharge for patients surviving acute myocardial infarction from the korea acute myocardial infarction registry. Clin Cardiol. 2015;38(6):350–356.
   Web of Science ®Google Scholar
• Opotowsky AR, McWilliams JM, Cannon CP. Gender differences in aspirin use among adults with coronary heart disease in the USA. Soc Gen Intern Med. 2007;22:55–61.
   Google Scholar
• Redfern J, Hyun K, Chew DP, et al. Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand. Heart. 2014;100:1281–1288.
   PubMed Web of Science ®Google Scholar
• Roth GA, Gillespie CW, Mokdad AA, et al. Aspirin use and knowledge in the community: a population- and health facility based survey for measuring local health system performance. BMC Cardiovasc Disord. 2014;14:16–22.
   PubMed Web of Science ®Google Scholar
• Kronish IM, Ye S. Adherence to cardiovascular medications: lessons learned and future directions. Prog Cardiovasc Dis. 2013;55(6):590–600.
   PubMed Web of Science ®Google Scholar
• Maddox TM, Chan PS, Spertus JA, et al. Variation in CAD secondary prevention prescriptions among outpatient cardiology practices: insights from the NCDR®. J Am Coll Cardiol. 2014;63(6):539–546.
   Web of Science ®Google Scholar
• Makam RCP, Erskine N, McManus DD, et al. Decade long trends (2001-2011) in the use of evidence-based medical therapies at the time of hospital discharge for patients surviving acute myocardial infarction. Am J Cardiol. 2016;118(12):1792–1797.
   PubMed Web of Science ®Google Scholar
• Redmond P, McDowell R, Grimes TC, et al. Unintended discontinuation of medication following hospitalization: a retrospective cohort study. BMJ Open. 2019;9(6):e024747.
   Web of Science ®Google Scholar
• Mangiapane S, Busse R. Prescription prevalence and continuing medication use for secondary prevention after myocardial infarction. Dtsch Arztebl Int. 2011;108(450):856–862.
   Google Scholar
• Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med. 2012;125:882–887.
   PubMed Web of Science ®Google Scholar
• Carballo D, Rodondi N, Auer R, et al. Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention. PLoS One. 2019;14(2):e0211464.
   Web of Science ®Google Scholar
• Gu Q, Dillon CF, Eberhardt MS, et al. Preventive aspirin and other antiplatelet medication use among U.S. adults aged >40 years: data from the national health and nutrition examination survey, 2011–2012. 433021. 2015;130:643–654.
   Google Scholar
• Rymer J, McCoy LA, Thomas L, et al. Persistence of evidence-based medication use after discharge from academic versus nonacademic hospitals among patients with non-ST-segment elevation myocardial infarction. Am J Cardiol. 2014;114(10):1479–1484.
   Web of Science ®Google Scholar
• Shore S, Jones PG, Maddox TM, et al. longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction. Heart. 2015;101(10):800–807.
   PubMed Web of Science ®Google Scholar
• Yasmina A, de Boer A, Deneer VHM, et al. Patterns of antiplatelet drug use after a first myocardial infarction during a 10-year period. Br J Clin Pharmacol. 2017;83:632–641.
   Web of Science ®Google Scholar
• Zheng SL, Roddick AJ. Association of aspirin use for primary prevention with cardiovascular events and bleeding events- a systematic review and meta-analysis. JAMA. 2019;321(3):277–287.
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’ Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373:1849–1860.
   PubMed Web of Science ®Google Scholar
• Juul-Möller S, Edvardsson N, Jahnmatz B, et al. Double-blind trial of aspirin in prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet. 1992;340:1421–1425.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Manson JE, Gaziano JM, et al. Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial. Annals of Internal Medicine, 1991, 114, 835-839.
   Google Scholar
• Huhn AS, Dunn KE. Why aren’t physicians prescribing more buprenorphine? J Subst Abuse Treat. 2017;78:1–7.
   PubMed Web of Science ®Google Scholar
• Arts DL, Abu-Hanna A, Medlock SK, et al. Effectiveness and usage of a decision support system to improve stroke prevention in general practice: A cluster randomized controlled trial. PLoS One. 2017. DOI:10.1371/journal.pone.0170974.
   Google Scholar
• Flodgren G, Goncalves-Bradley DC, Summerbell CD. Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity (Review). Cochrane Database Syst Rev. 2017;11:Art. No.: CD000984. DOI:10.1002/14651858.CD000984.pub3
   Web of Science ®Google Scholar
• Guiriguet C, Munoz-Ortiz L, Rivero I, et al. Alerts in electronic medical records to promote a colorectal cancer screening programme. Br J Gen Pract. 2016. DOI:10.3399/bjgp16X685657.
   Web of Science ®Google Scholar
• Karlsson LO, Nilsson S, Bang M, et al. A clinical decision support tool for improving adherence to guidelines on anticoagulant therapy in patients with atrial fibrillation at risk of stroke: A cluster-randomized trial in a Swedish primary care setting (the CDS-AF study). PLoS Med. 2018. DOI:10.1371/journal.pmed.1002528.
   Web of Science ®Google Scholar
• Khalil H, Bell B, Chambers H, et al. Professional, structural and organisational interventions in primary care for reducing medication errors (Review). Cochrane Database Syst Rev. 2017;(10):Art. No.: CD003942. DOI:10.1002/14651858.CD003942.pub3
   Web of Science ®Google Scholar
• Konerman MA, Thomson M, Gray K, et al. Impact of an electronic health record alert in primary care on increasing hepatitis C screening and curative treatment for baby boomers. Hepatology. 2017;66(6):1805–1813.
   Web of Science ®Google Scholar
• McKibbon KA, Lokker C, Handler SM, et al. The effectiveness of integrated health information technologies across the phases of medication management: a systematic review of randomized controlled trials. J Am Med Inform Assoc. 2012;19:22–30.
   Web of Science ®Google Scholar
• Dondo TB, Hall M, Timmis AD, et al. Geographic variation in the treatment of non-ST-segment myocardial infarction in the English National Health Service: a cohort study. BMJ Open. 2016;6:e011600.
   Web of Science ®Google Scholar
• Aboa-Eboulé C, Mengue D, Benzenine E, et al. How accurate is the reporting of stroke in hospital discharge data? A pilot validation study using a population-based stroke registry as control. J Neurol. 2013;260:605–613.
   Web of Science ®Google Scholar
• Burkhardt M, Nienaber U, Holstein JH, et al. Trauma registry record linkage: methodological approach to benefit from complementary data using the example of the German pelvic injury register and the traumaRegister DGU®. BMC Med Res Methodol. 2013;13:30–36.
   Web of Science ®Google Scholar
• Gurevic Y, McFarlane A, Morris K, et al. Estimating the number of coronary artery bypass graft and percutaneous coronary intervention procedures in Canada: A comparison of cardiac registry and Canadian institute for health information data sources. Can J Cardiol. 2010;26(7):e249–e253.
   Web of Science ®Google Scholar
• Hoeijmakers F, Beck N, Wouters MWJM, et al. National quality registries: how to improve the quality of data? J Thorac Dis. 2018;10(Suppl 29):S3490–S3499.
   Google Scholar
• Lee SJC, Grobe JE, Tiro JA. Assessing race and ethnicity data quality across cancer registries and EMRs in two hospitals. J Am Med Inform Assoc. 2016;23:627–634.
   Web of Science ®Google Scholar
• Seagrave KG, Naylor J, Armstrong E, et al. Data quality audit of the arthroplasty clinical outcomes registry NSW. BMC Health Serv Res. 2014;14:512–517.
   Web of Science ®Google Scholar
• Sirirungreung A, Buasom R, Jiraphongsa C, et al. Data reliability and coding completeness of cancer registry information using reabstracting method in the national cancer institute: Thailand, 2012 to 2014. J Global Oncol. 2018. DOI:10.1200/JGO.17.00147.
   Google Scholar
• Whedon J, Fulton G, Herr CH, et al. Trauma patients without a trauma diagnosis: the data gap. J Trauma. 2009;67(4):822–828.
   Google Scholar
• Boggon R, van Staa TP, Timmis A, et al. Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction- a hospital registry-primary care linked cohort (MINAP-GPRD). Eur Heart J. 2011;32:2376–2386.
   PubMed Web of Science ®Google Scholar
• Fanaroff AC, Roe MT. Contemporary reflections on the safety of long-term aspirin treatment for the secondary prevention of cardiovascular disease. Drug Saf. 2016;39(8):715–727.
   Web of Science ®Google Scholar
• Ismail N, Jordan KP, Rao S, et al. Incidence and prognostic impact of post discharge bleeding post acute coronary syndrome within an outpatient setting: a systematic review. BMJ Open. 2019;9:e023337.
   Web of Science ®Google Scholar